QIAGEN Digital Insights

10/12/2026

This October, we’re serving up some scary good science. See how good bioinformatics can make short work of your data – no magic, witchcraft or supernatural explanations involved 🧙‍♂️

Our expert-led webinars will explore practical workflows, best practices and fresh perspectives to further your discovery, translational and clinical research.

Make your next research challenge a little less frightening 👻 Save your seat ➡️ https://digitalinsights.qiagen.com/webinars-and-events/?cmpid=CM_QDI-DISC_Oct-events_1026_SM_MetaOrg

10/30/2025

Single-cell data analysis should be accessible to every biologist, enabling them to generate meaningful results that drive their next experiment. In our webinar on Nov. 5, we’ll show how you can perform small or large analyses with a user-friendly GUI, skipping the command line altogether. Have spatial data? You can add that, too.

Save your seat 👉 https://qiagen.zoom.us/webinar/register/8517616739509/WN_rI8ua5XEQxyADXIcljDecA

10/29/2025

QIAGEN will be at the Association for Molecular Pathology Annual Meeting in Boston, MA! We’ve prepared insightful corporate sessions for you, as well as an exclusive workshop where you can experience for Oncology firsthand. Drop by booth 637 to get to know our molecular solutions better. Meet with us 👉 https://digitalinsights.qiagen.com/amp-2025/?cmpid=CM_QDI-CLIN_AMP_1025_SM_MetaOrg

10/28/2025

💡 Short-read high-throughput sequencing (HTS) is a powerful, unbiased approach that greatly enhances virus detection by analyzing nucleic acid sequences to detect a broad array of known and unknown viruses – without prior assumptions.

See how researchers at global institutes investigated the sensitivity and efficacy of HTS for detecting adventitious viruses in our new app note 👉 https://digitalinsights.qiagen.com/explore/qiagen-gmp/qpro-11165-gmp-app-n?utm_source=CM_QDI-DISC_GMP-HTS_1025_SM_MetaOrg

10/24/2025

Clarifications on QIAGEN blog post on the 2025 American Society of Human Genetics (ASHG) Annual Meeting

A recent blog post published on QIAGEN Digital Insights’ website included references to incorrect cost estimates associated with Roche’s new Axelios 1 sequencing platform used in the recent world-record genome sequencing demonstration at the ASHG Annual Meeting.

QIAGEN apologizes and wishes to clarify that its price estimate mentioned in the post was solely based on our general market observations and publicly available commentary. Roche has not disclosed official cost-per Gb or cost per genome, and the figures cited should not be interpreted as an official statement on pricing.

In addition, we would like to clarify that Franklin by QIAGEN bioinformatics solutions was used as part of the tertiary analysis workflow in the study published in the New England Journal of Medicine, but the official world record is set for DNA sequencing technique that covered Roche's primary and secondary analysis processes.

10/24/2025

Next Monday, Oct. 27, is Neo4j’s Boston GraphTalk at Rochambeau, where Dr. Venkatesh Moktali will discuss the use of curated causal knowledge in for 💊 Hear about the latest advances from him and other industry experts – get your free pass 👉 https://events.neo4j.com/bostongraphtalk

10/17/2025

The IPA Fall Release is here! 🍂 Combined with 123K new expert-curated findings, this release brings:

⭐ A new IPA Interpret home page – find all your AI-enhanced reports in one place
⭐ Filtering in the dataset volcano plot of IPA Interpret
⭐ Up to 5x faster analyses with the default biological filter settings

Learn more 👉 https://digitalinsights.qiagen.com/news/blog/discovery/the-qiagen-ipa-fall-release-is-here-%f0%9f%8d%82/?cmpid=CM_QDI-DISC_IPA-Fall_1025_SM_MetaOrg

10/16/2025

(YF), an acute viral hemorrhagic disease spread through the bite of infected mosquitoes, remains a serious health threat in Africa and South America. While the live-attenuated 17D vaccine has proven effective and generally safe, rare severe side effects and limited supplies have prompted research into safer and scalable modern vaccines. 💉

Get a closer look at as Sanofi tests vYF-247, their next-gen YF vaccine candidate, across -relevant production stages 👉 https://digitalinsights.qiagen.com/explore/qiagen-gmp/qpro-11251-app-note?xs=953698&utm_source=CM_QDI-DISC_GMP-YF-AN_1025_SM_MetaOrg

10/14/2025